Physician profile
Gary Nanez
NPI 1669479127
$4,809.27
in general payments reported to CMS, 2019-2025
17 companies · $842 in 2025
The $842 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.69 · 2020: $86.41 · 2021: $15.22 · 2022: $2,221 · 2023: $536 · 2024: $1,093 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,362 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,362.40 |
| Education | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,436.49 | 2022 | |
| Genzyme Corporation | $625.81 | 2022-2025 | |
| Stryker Corporation | $605.08 | 2023-2025 | Scopis Ent, Clarifix Cryotherapy Device, Audion Et Dilation System |
| Regeneron Healthcare Solutions, INC. | $573.37 | 2022-2025 | Dupixent |
| Integra Lifesciences Corporation | $256.14 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Glaxosmithkline, LLC. | $251.07 | 2022-2025 | Nucala |
| Acclarent, INC | $250.84 | 2022 | |
| Intuitive Surgical, INC. | $176.11 | 2022 | |
| Aerin Medical INC. | $167.45 | 2024-2025 | |
| Intersect Ent, INC. | $136.05 | 2022 | |
| Smith+Nephew, INC. | $103.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $88.62 | 2020-2025 | |
| Karl Storz Endoscopy-America | $50.23 | 2020 | |
| Medtronic, INC. | $33.65 | 2022-2023 | Propel |
| Ambu INC. | $23.40 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $15.77 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Nanez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.